GlaxoSmithKline Pharmaceuticals sells trademarks pertaining to 'lodex', 'Ostocalcium' brands in India

17 Mar 2022 Evaluate

GlaxoSmithKline Pharmaceuticals has completed the transaction relating to sale of the Company's trademarks 'pertaining to 'lodex' and 'Ostocalcium' brands in India to GlaxoSmithKline Asia. Earlier, in July 2021, the company had received approval to transfer of the trademarks pertaining to 'lodex' and 'Ostocalcium' brands in India.

GlaxoSmithKline Pharmaceuticals is an Indian subsidiary of GlaxoSmithKline plc. The company business has a broad portfolio of innovative and established medicines, with leadership positions in respiratory and HIV.

Glaxosmithkline Phar Share Price

2464.90 -19.80 (-0.80%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×